Novast
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Novast is publicly traded on SHZ under the ticker 301569.SZ.
NOVAST Laboratories, Limited develops, manufactures, and sells prescription drug formulations. The company produces controlled-release formulations, including extended-release and sustained-release tablets and capsules, as well as low-dose drug formulations. Its products include Metoprolol Succinate Extended-Release Tablets, Nifedipine Extended-Release Tablets, Diltiazem Hydrochloride Extended-Release Capsules,...
Can you invest in Novast?
Yes. Novast is publicly traded on SHZ under the ticker 301569.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.